Show Summary Details
Page of

Global burden of disease: causes, levels, and intervention strategies 

Global burden of disease: causes, levels, and intervention strategies

Chapter:
Global burden of disease: causes, levels, and intervention strategies
Author(s):

Ramanan Laxminarayan

and Dean Jamison

DOI:
10.1093/med/9780199204854.003.0301
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2015. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy).

date: 30 March 2017

Recent decades have seen remarkable progress in quantifying the burden of disease in low- and middle-income countries and in gathering evidence on the effectiveness and cost-effectiveness of health interventions. This chapter reviews the major sources of death and disability in these countries and draws lessons from recent analytical work on the cost-effectiveness of interventions to address this disease burden. Four essential messages emerge: 1 Life expectancies worldwide improved dramatically from 1960 to 2002, with the largest increases being in low- and middle-income countries. 2 Improvements in immunization coverage, access to basic education, and spread of low-cost but powerful medical technologies—rather than income growth—appear to have been the primary causes of the gains in life expectancy. 3 The decline in childhood infectious disease burden has been partially offset by a dramatic, age-related increase in the incidence of HIV/AIDS and of chronic, noncommunicable diseases (cardiovascular disease, stroke, diabetes, cancer, psychiatric disorders), especially in low- and middle-income countries. 4 Cost-effective interventions can—if selected carefully and adopted widely—address the challenges of lowering under-5 and maternal mortality, and the burden of noncommunicable diseases.

Interventions that in appropriate circumstances can cost less (sometimes much less) than US$100 per disability-adjusted life year (DALY) include: ◆ improving care of children <28 days old ◆ expanded immunization coverage with standard child vaccines ◆ adding vaccines against additional diseases to the standard child immunization program (particularly Haemophilus influenzae B, hepatitis B) ◆ switching to use of combination drugs against malaria (when resistant to previous standard treatments) ◆ some measures to prevent and treat HIV/AIDS ◆ taxing tobacco products ◆ treating acute myocardial infarction with an inexpensive set of drugs ◆ detecting and treating cervical cancer ◆ operating a basic surgical ward at the district hospital level that focuses on trauma, high-risk pregnancy, and other common surgically treatable conditions

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can''t find the answer there, please contact us.